Late last year, Nature Partner Journal, npj Digital Medicine published findings from Fitbit’s COVID-19 study, which aims to determine whether the wearable can help build an algorithm to detect COVID-19 before symptoms start.
The published results show that breathing rate, resting heart rate and heart rate variability (HRV) are all useful metrics for indicating the onset of illness, making wearables a key tool in the fight against COVID-19, as it’s clear that patients' bodies may signal impact from the disease before more noticeable symptoms appear.
On this episode of Let’s Talk Medtech, MD+DI’s managing editor Omar Ford spoke with Dr. Conor Heneghan Lead Research Scientist at Fitbit about the study. Click here for the episode.
0 comments
Hide comments
